The DNA vaccine in this report
refers to the vaccines manufactured using recombinant DNA technology. The
advent of these vaccines has revolutionized the healthcare market. These
vaccines are more effective, as well as have less side-effects associated with
them as compared to traditional vaccines. Various vaccines have been introduced
in the market based on this technique. Some of the major DNA vaccines include
GlaxoSmithKline's Engerix-B, Twinrix, and Fendrix; Merck's Gardasil, and
Recombivax HB; Protein Sciences Corporation's Flublok, etc. Currently, the
researchers are engaged in developing genetic vaccines for humans. Animal
genetic vaccines are already present in the market. These vaccines are third
generation vaccines, and contain DNA that codes for specific proteins from a
pathogen. This DNA is injected into host body and produces protein for which
the body generates immune response.
View Full Report with TOC @ http://www.radiantinsights.com/research/global-dna-vaccine-market-outlook-2022
This comprehensive report by
RNCOS entitled "Global DNA Vaccine Market Outlook 2022" provides an
in-depth analysis of the global DNA Vaccines market, presenting readers a profound
understanding of the various challenges, drivers, and developments in this
industry. The study has publicized that though the numbers of DNA vaccines that
target the human clinical segment are relatively fewer in number, however due
to high sales of these vaccines, the DNA vaccine market is estimated to reach
US$ 7 Billion by the end of 2016.
The report also contains detailed
and in-depth analysis of the segmentation of the DNA vaccines market based on
types of DNA vaccines, therapeutic indication, end-users, and geography. Based
on the type, the DNA vaccines market is divided into recombinant protein and
genetic. In 2016, recombinant protein segment is estimated to account for
largest share in the market. This large share is attributed to the presence of
high number of recombinant protein vaccines in the market.
Based on end-user, the report
segments the market into human and animal. The majority of DNA vaccines
available in the market are targeted for humans. Moreover, the strong pipeline
of human targeted vaccines is likely to aid the market growth.
Request A Sample Copy of This Report at: http://www.radiantinsights.com/research/global-dna-vaccine-market-outlook-2022/request-sample
Based on geography, the report
further divides the market into four regions, namely, North America, Europe,
Asia-Pacific, and Rest of the World. North America is the largest market for
DNA vaccines. The large share of the market is attributed to government's
initiatives to immunize citizens, coupled with high awareness regarding the
benefits of genetic vaccines targeted towards animals. The Asia-Pacific region
is slated to witness the highest growth in the forecasted period. This growth
is likely to be driven by rising awareness of people regarding the advantages
of immunization against HPV and Hepatitis B.
The report also includes pipeline
analysis based on the type of phase, therapeutic indications, and type of
diseases for which the vaccines have been designed, such as infectious and
vector borne diseases, and various types of cancers.
Major players in the DNA Vaccines
market are also profiled with company overview, financial overview, product
portfolios, recent developments, and strengths and weaknesses. The last section
of the report discusses about the recommendations which could help the DNA
vaccine market grow at a faster pace. Conclusively, the research will prove to
be a useful resource for all debut makers in DNA vaccine industry, and
potential investors.
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to
meet their market research and business intelligence requirements. We assist
and facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research partnerships/
tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant
Insights, Inc
Contact Person: Michelle
Thoras
Email:
sales@radiantinsights.com
Phone: (415) 349-0054
Address: 28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Comments
Post a Comment